Increasing clinical virulence in two decades of the Italian HIV epidemic

PLoS Pathogens

Volumn 5, Issue 5, 2009, Pages

  Müller, Viktor ^a   Maggiolo, Franco ^b   Suter, Fredy ^b   Ladisa, Nicoletta ^c   De Luca, Andrea ^d   Antinori, Andrea ^e   Sighinolfi, Laura ^f   Quiros Roldan, Eugenia ^g   Carosi, Giampiero ^g   Torti, Carlo ^g  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b OSPEDALI RIUNITI   (Italy)

^c POLICLINICO   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^f S ANNA HOSPITAL   (Italy)

^g UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG USE; EPIDEMIC; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; MAJOR CLINICAL STUDY; MALE; VIRUS VIRULENCE; EVOLUTION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; PATHOGENICITY; PATHOLOGY; RISK; STATISTICAL MODEL; TECHNIQUE; TIME; VIROLOGY; VIRULENCE;

CD4 LYMPHOCYTE COUNT; DISEASE OUTBREAKS; EVOLUTION; HIV; HIV INFECTIONS; HUMANS; ITALY; LINEAR MODELS; METHODS; RISK; TIME FACTORS; VIRULENCE;

EID: 67249156626     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000454     Document Type: Article

References (30)

1. Korber B, Muldoon M, Theiler J, Gao F, Gupta R, et al. (2000) Timing the ancestor of the HIV-1 pandemic strains. Science 288: 1789-1796. (Pubitemid 30399011)
2. Ashton LJ, Learmont J, Luo K, Wylie B, Stewart G, et al. (1994) HIV infection in recipients of blood products from donors with known duration of infection. Lancet 344: 718-720. (Pubitemid 24281425)
3. Ward JW, Bush TJ, Perkins HA, Lieb LE, Allen JR, et al. (1989) The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med 321: 947-952. (Pubitemid 19244054)
4. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, et al. (1995) Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270: 988-991.
5. Kanki PJ, Hamel DJ, Sankale JL, Hsieh C, Thior I, et al. (1999) Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 179: 68-73. (Pubitemid 29028340)
6. Sinicco A, Fora R, Raiteri R, Sciandra M, Bechis G, et al. (1997) Is the clinical course of HIV-1 changing? Cohort study. BMJ 314: 1232-1237. (Pubitemid 27173907)
7. Vanhems P, Lambert J, Guerra M, Hirschel B, Allard R (1999) Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study. J Infect Dis 180: 1803-1808.
8. Dorrucci M, Phillips AN, Longo B, Rezza G (2005) Changes over time in post-seroconversion CD4 cell counts in the Italian HIV-Seroconversion Study: 1985-2002. AIDS 19: 331-335. (Pubitemid 40396565)
9. Dorrucci M, Rezza G, Porter K, Phillips A (2007) Temporal trends in postseroconversion CD4 cell count and HIV load: the Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985-2002. J Infect Dis 195: 525-534. (Pubitemid 46214395)
10. Gali Y, Berkhout B, Vanham G, Bakker M, Back NK, et al. (2007) Survey of the temporal changes in HIV-1 replicative fitness in the Amsterdam Cohort. Virology 364: 140-146. (Pubitemid 46829281)
11. Crum-Cianflone N, Eberly L, Zhang Y, Ganesan A, Weintrob A, et al. (2009) Is HIV becoming more virulent? Initial CD4 cell counts among HIV seroconverters during the course of the HIV epidemic: 1985-2007. Clin Infect Dis 48: 1285-1292.
12. Holmberg SD, Conley LJ, Luby SP, Cohn S, Wong LC, et al. (1995) Recent infection with human immunodeficiency virus and possible rapid loss of CD4 T lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol 9: 291-296.
13. O'Brien TR, Hoover DR, Rosenberg PS, Chen B, Detels R, et al. (1995) Evaluation of secular trends in CD4+ lymphocyte loss among human immunodeficiency virus type 1 (HIV-1)-infected men with known dates of seroconversion. Am J Epidemiol 142: 636-642.
14. CASCADE Collaboration (2000) Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet 355: 1131-1137.
15. CASCADE Collaboration (2003) Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion. J Acquir Immune Defic Syndr 34: 76-83. (Pubitemid 37100116)
16. Herbeck JT, Gottlieb GS, Li X, Hu Z, Detels R, et al. (2008) Lack of evidence for changing virulence of HIV-1 in North America. PLoS ONE 3: e1525. doi:10.1371/journal.pone.0001525.
17. Müller V, Ledergerber B, Perrin L, Klimkait T, Furrer H, et al. (2006) Stable virulence levels in the HIV epidemic of Switzerland over two decades. AIDS 20: 889-894. (Pubitemid 43731571)
18. Keet IP, Veugelers PJ, Koot M, de Weerd MH, Roos MT, et al. (1996) Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1993. AIDS 10: 1601-1602. (Pubitemid 26370681)
19. Arien KK, Troyer RM, Gali Y, Colebunders RL, Arts EJ, et al. (2005) Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time. AIDS 19: 1555-1564. (Pubitemid 41502667)
20. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, et al. (1996) Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272: 1167-1170. (Pubitemid 26001148)
21. Arien KK, Vanham G, Arts EJ (2007) Is HIV-1 evolving to a less virulent form in humans? Nat Rev Microbiol 5: 141-151.
22. Herrera M, Garcia-Arriaza J, Pariente N, Escarmis C, Domingo E (2007) Molecular basis for a lack of correlation between viral fitness and cell killing capacity. PLoS Pathog 3: e53. doi: 10.1371/journal.ppat.0030053. (Pubitemid 46683485)
23. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, et al. (2007) A whole-genome association study of major determinants for host control of HIV-1. Science 317: 944-947. (Pubitemid 47301321)
24. Lawn SD (2004) AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. J Infect 48: 1-12. (Pubitemid 38072197)
25. Berzsenyi MD, Bowden DS, Roberts SK (2005) GB virus C: insights into coinfection. J Clin Virol 33: 257-266.
26. Joy R, Druyts EF, Brandson EK, Lima VD, Rustad CA, et al. (2008) Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. J Acquir Immune Defic Syndr 47: 500-505.
27. Pillay D, Bhaskaran K, Jurriaans S, Prins M, Masquelier B, et al. (2006) The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy. AIDS 20: 21-28. (Pubitemid 41818110)
28. Maljkovic Berry I, Ribeiro R, Kothari M, Athreya G, Daniels M, et al. (2007) Unequal evolutionary rates in the human immunodeficiency virus type 1 (HIV-1) pandemic: the evolutionary rate of HIV-1 slows down when the epidemic rate increases. J Virol 81: 10625-10635. (Pubitemid 47463336)
29. Fraser C, Hollingsworth TD, Chapman R, de Wolf F, Hanage WP (2007) Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc Natl Acad Sci U S A 104: 17441-17446. (Pubitemid 350219857)
30. Crawley MJ (2007) The R Book. Chichester: Wiley.